- Home
- CVI vs NAMS Comparison
CVI vs NAMS Comparison
Compare CVI & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVI
- NAMS
- Stock Information
- Founded
- CVI 1906
- NAMS 2019
- Country
- CVI United States
- NAMS Netherlands
- Employees
- CVI N/A
- NAMS N/A
- Industry
- CVI Integrated oil Companies
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- CVI Energy
- NAMS Health Care
- Exchange
- CVI Nasdaq
- NAMS Nasdaq
- Market Cap
- CVI 3.2B
- NAMS 3.1B
- IPO Year
- CVI 2007
- NAMS N/A
- Fundamental
- Price
- CVI $36.92
- NAMS $30.67
- Analyst Decision
- CVI Strong Sell
- NAMS Strong Buy
- Analyst Count
- CVI 4
- NAMS 10
- Target Price
- CVI $23.25
- NAMS $41.40
- AVG Volume (30 Days)
- CVI 2.3M
- NAMS 1.0M
- Earning Date
- CVI 10-27-2025
- NAMS 11-05-2025
- Dividend Yield
- CVI N/A
- NAMS N/A
- EPS Growth
- CVI N/A
- NAMS N/A
- EPS
- CVI N/A
- NAMS N/A
- Revenue
- CVI $7,188,000,000.00
- NAMS $64,006,000.00
- Revenue This Year
- CVI N/A
- NAMS N/A
- Revenue Next Year
- CVI $6.66
- NAMS $1.67
- P/E Ratio
- CVI N/A
- NAMS N/A
- Revenue Growth
- CVI N/A
- NAMS 762.15
- 52 Week Low
- CVI $15.10
- NAMS $14.06
- 52 Week High
- CVI $38.30
- NAMS $31.81
- Technical
- Relative Strength Index (RSI)
- CVI 70.10
- NAMS 69.35
- Support Level
- CVI $35.50
- NAMS $27.14
- Resistance Level
- CVI $37.66
- NAMS $28.91
- Average True Range (ATR)
- CVI 1.42
- NAMS 1.37
- MACD
- CVI 0.11
- NAMS 0.40
- Stochastic Oscillator
- CVI 81.84
- NAMS 86.13
About CVI CVR Energy Inc.
CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.